Larimar Therapeutics Inc. sell Lokrim
Start price
07.01.25
/
10%
€3.92
Target price
07.01.26
-
Performance (%)
-27.04%
End price
08.01.26
€2.86
Summary
This prediction ended on 08.01.26 with a price of €2.86. The price of Larimar Therapeutics Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -27.04%. Lokrim has 10% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Larimar Therapeutics Inc. | 16.541% | 16.541% | -8.824% |
| iShares Core DAX® | -1.764% | 2.259% | 15.847% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 4.686% |
| iShares Nikkei 225® | -2.451% | 4.086% | 16.083% |
| iShares S&P 500 | -2.252% | -0.151% | 1.636% |
According to Lokrim what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?
Pros
Cons
Below average Marketposition
Probably not worthwhile Investment
Revenue decline/stagnation expected
Comments by Lokrim for this prediction
In the thread Zafgen Inc. diskutieren
Sell Larimar Therapeutics Inc.
In the thread Trading Zafgen Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Lokrim for Larimar Therapeutics Inc.
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€11.40
17.05.21
17.05.21
-
17.05.22
17.05.22
-79.82%
18.05.22
18.05.22
